Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cutera, Inc. | TJ9 | Mar 31, 2025 | 0.08 | 0.00 |
CVB Financial Corporation | BCV | Mar 31, 2025 | 16.60 | -3.49 |
CVC CAPITAL PARTNERS PLC | Z1W | Mar 31, 2025 | 18.50 | -4.19 |
CVD Equipment Corporation | 0V3 | Mar 31, 2025 | 2.74 | -3.52 |
CVR Energy Inc | FL9 | Mar 31, 2025 | 17.86 | -0.81 |
CVS Group Plc | 4C9 | Mar 31, 2025 | 11.90 | -1.65 |
CVS HEALTH CDR(REG.S) | CVS0 | Mar 31, 2025 | 10.10 | -0.98 |
CVS Health Corporation | CVS | Mar 31, 2025 | 61.74 | -1.03 |
CVW CLEANTECH INC. | TMD0 | Mar 31, 2025 | 0.52 | -0.96 |
CY4GATE S.P.A. | 68H | Mar 31, 2025 | 4.04 | -2.18 |
Cyan AG | CYR | Mar 31, 2025 | 3.02 | +3.42 |
CyanConnode Holdings Plc | CUAN | Mar 31, 2025 | 0.13 | +0.76 |
Cyber Security 1 | 7CS | Mar 31, 2025 | 0.00 | 0.00 |
CyberAgent,Inc. | CL2 | Mar 31, 2025 | 6.95 | -2.80 |
CyberArk Software Ltd. - Ordinary Shares | CYB | Mar 31, 2025 | 295.90 | -5.43 |
CyberCatch Global | D0K | Mar 31, 2025 | 0.48 | +2.11 |
Cyberdyne Inc | 8C4 | Mar 31, 2025 | 1.12 | -3.79 |
CYBEROO S.P.A. | K97 | Mar 31, 2025 | 1.80 | +9.76 |
CYBERTRUST JAPAN | 5U2 | Mar 31, 2025 | 14.20 | -4.05 |
Cybin | R7E | Mar 31, 2025 | 5.90 | -4.07 |
Cyfrowy Polsat SA | CP9 | Mar 31, 2025 | 3.61 | -0.17 |
Cymbria Corp | CYOA | Mar 31, 2025 | 47.40 | +0.42 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Mar 31, 2025 | 0.10 | -1.90 |
Cytokinetics, Incorporated | KK3A | Mar 31, 2025 | 36.80 | -5.64 |
Cytomed Therapeutics | F98 | Mar 31, 2025 | 2.00 | +5.82 |
CytomX Therapeutics, Inc. | 6C1 | Mar 31, 2025 | 0.57 | +1.16 |
CYTOPHAGE TECHN. LTD. | 70G | Mar 31, 2025 | 0.08 | +8.28 |
Cytosorbents Corporation | HQE1 | Mar 31, 2025 | 0.89 | -1.33 |
Cyviz | 8P9 | Mar 31, 2025 | 2.23 | -11.86 |
CZG - Ceska Zbrojovka Group SE | 6QS | Mar 31, 2025 | 30.15 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.